We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Synlab AG | TG:SYAB | Tradegate | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.12 | 1.09% | 11.14 | 11.02 | 11.26 | 11.18 | 11.00 | 11.18 | 2,644 | 20:58:00 |
From Jun 2023 to Jun 2024
By Andrea Figueras
Synlab said Tuesday that it has sold its Swiss operations to Australian peer Sonic Healthcare, which said it is paying 150 million Swiss francs ($167.5 million) for the business.
Munich-based Synlab, a provider of laboratory-diagnostic services, said the deal will be positive for its adjusted earnings margin and allow it to reduce its adjusted net debt. The sale received the required approvals of antitrust authorities, Synlab said.
Sonic separately said it expects the deal will be accretive to earnings per share from next year.
For the second half of 2023, Synlab had expected revenue around 50 million euros ($54.5 million) from its operations in Switzerland. Despite the transaction, which is expected to be closed by July 3, Synlab's revenue guidance for the current year remains the same at around EUR2.7 billion.
Write to Andrea Figueras at andrea.figueras@wsj.com
(END) Dow Jones Newswires
June 27, 2023 04:36 ET (08:36 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.
1 Year Synlab Chart |
1 Month Synlab Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
